Accueil / Tag Archives: New-York (page 10)

Tag Archives: New-York

Teva to Present New Data on AUSTEDO® (deutetrabenazine) Tablets at Psych Congress 2019

Wednesday, October 2nd 2019 at 12:30pm UTC Three new presentations evaluate AUSTEDO tablets for the treatment of tardive dyskinesia in adults JERUSALEM & PARSIPPANY, N.J.–(BUSINESS WIRE)– Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that new AUSTEDO® (deutetrabenazine) data will be presented at the 32nd annual Psych Congress, …

Plus »

MC10, Inc. Announces Collaboration with University of Rochester: Development Novel Digital Biomarkers for Central Nervous System Diseases

Wednesday, October 2nd 2019 at 1:07pm UTC ROCHESTER, N.Y. & LEXINGTON, Mass.–(BUSINESS WIRE)– MC10, Inc., creators of the innovative wearable device BioStamp nPoint, and the University of Rochester announced today a collaboration on advancing methods of assessing Central Nervous System (CNS) diseases. The collaboration will utilize the BioStamp nPoint system …

Plus »

MC10, Inc. Announces Collaboration with University of Rochester: Development Novel Digital Biomarkers for Central Nervous System Diseases

Wednesday, October 2nd 2019 at 1:07pm UTC ROCHESTER, N.Y. & LEXINGTON, Mass.–(BUSINESS WIRE)– MC10, Inc., creators of the innovative wearable device BioStamp nPoint, and the University of Rochester announced today a collaboration on advancing methods of assessing Central Nervous System (CNS) diseases. The collaboration will utilize the BioStamp nPoint system …

Plus »

LineaRx’s iCTC Platform for Isolation of Circulating Tumor Cells Shows Superior Correlation over PSA as a Biomarker in Prostate Cancer Trial

Tuesday, October 1st 2019 at 12:30pm UTC LineaRx Platform Used in Phase II trial in recurrent prostate cancer demonstrates the number of circulating tumor cells correlates more directly with disease status STONY BROOK, N.Y.–(BUSINESS WIRE)– class= »bwalignl »> LineaRx, Inc., the majority-owned subsidiary of Applied DNA Sciences, Inc. (NASDAQ: APDN) focused on …

Plus »

LineaRx’s iCTC Platform for Isolation of Circulating Tumor Cells Shows Superior Correlation over PSA as a Biomarker in Prostate Cancer Trial

Tuesday, October 1st 2019 at 12:30pm UTC LineaRx Platform Used in Phase II trial in recurrent prostate cancer demonstrates the number of circulating tumor cells correlates more directly with disease status STONY BROOK, N.Y.–(BUSINESS WIRE)– class= »bwalignl »> LineaRx, Inc., the majority-owned subsidiary of Applied DNA Sciences, Inc. (NASDAQ: APDN) focused on …

Plus »

White Oak Healthcare Finance Provides $241 Million Financing for a 19 Facility Skilled Nursing Portfolio

Tuesday, October 1st 2019 at 1:00pm UTC NEW YORK–(BUSINESS WIRE)– White Oak Healthcare Finance, LLC (“White Oak”) today announced it acted as administrative agent and lead lender on the funding of a $241 million senior credit facility secured by 19 skilled nursing facilities diversified across 6 states. The total portfolio …

Plus »

White Oak Healthcare Finance Provides $241 Million Financing for a 19 Facility Skilled Nursing Portfolio

Tuesday, October 1st 2019 at 1:00pm UTC NEW YORK–(BUSINESS WIRE)– White Oak Healthcare Finance, LLC (“White Oak”) today announced it acted as administrative agent and lead lender on the funding of a $241 million senior credit facility secured by 19 skilled nursing facilities diversified across 6 states. The total portfolio …

Plus »

Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates

Tuesday, October 1st 2019 at 8:30pm UTC Agreement covers manufacturing of clinical supply for Cellectis’ UCART pipeline Manufacturing to take place at Lonza’s GMP site in Geleen, Netherlands BASEL, Switzerland & NEW YORK–(BUSINESS WIRE)– Regulatory News: Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Euronext Growth: ALCLS – Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused …

Plus »

Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates

Tuesday, October 1st 2019 at 8:30pm UTC Agreement covers manufacturing of clinical supply for Cellectis’ UCART pipeline Manufacturing to take place at Lonza’s GMP site in Geleen, Netherlands BASEL, Switzerland & NEW YORK–(BUSINESS WIRE)– Regulatory News: Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Euronext Growth: ALCLS – Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused …

Plus »

Cold Spring Harbor Laboratory Press Publishes Conscience and Courage, the Remarkable Life Story of Former Genzyme CEO and Rare Disease Pioneer, Henri Termeer

Tuesday, October 1st 2019 at 8:39pm UTC Author John Hawkins has written a well-researched biography about Termeer’s legacy—how he built a global biotech giant, Genzyme, and mentored a new generation of business leaders who continue to relentlessly challenge conventional innovation models and bring new novel treatments to patients around the …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.